|
Volumn 1, Issue 3, 2001, Pages 177-179
|
Application of data mining for examining polypharmacy and adverse effects in cardiology patients
|
Author keywords
Cardiovascular patients; Data mining; Drug interactions; Polypharmacy
|
Indexed keywords
ADENOSINE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARBAMAZEPINE;
CYTOKINE;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENDOTHELIN RECEPTOR ANTAGONIST;
ENKEPHALINASE INHIBITOR;
LOOP DIURETIC AGENT;
PROTEIN INHIBITOR;
SPIRONOLACTONE;
STATIN;
DRUG;
BIOSAFETY;
CARDIOLOGY;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COMORBIDITY;
DISEASE SEVERITY;
DRUG EFFECT;
FATALITY;
FOOD AND DRUG ADMINISTRATION;
HEART BLOCK;
HEART FAILURE;
HUMAN;
HYPOGLYCEMIA;
MEDICAL RECORD;
MINING;
PATIENT CARE;
POLYPHARMACY;
PRIORITY JOURNAL;
REVIEW;
SCALE UP;
SIDE EFFECT;
ARTICLE;
DRUG INTERACTION;
FACTUAL DATABASE;
HEART DISEASE;
STATISTICAL ANALYSIS;
STATISTICS;
UNITED STATES;
CLINICAL TRIALS;
DATA INTERPRETATION, STATISTICAL;
DATABASES, FACTUAL;
DRUG INTERACTIONS;
HEART DISEASES;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 0035553483
PISSN: 15307905
EISSN: None
Source Type: Journal
DOI: 10.1385/CT:1:3:177 Document Type: Review |
Times cited : (10)
|
References (10)
|